Aqua Bio Technology ASA – Key information relating to the Subsequent Offering

18.10.2024 08:53:02 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
Reference is made to the announcement by Aqua Bio Technology ASA on 18 October 2024 concerning the successful placement of the conditional private placement with total gross proceeds of approximately NOK 115 million, and a contemplated subsequent offering (the “Subsequent Offering”).
 
Key information for the Subsequent Offering is set out below:
 
 Date on which the terms of the Subsequent        17 October 2024
 Offering was announced:
 
 Last day including right:                                       17 October 2024
 
 First day excluding right:                                     18 October 2024
 
 Record date:                                                          21 October 2024
 
 EGM date:                                                              On or about 12 November 2024 (to be summoned)
 
 Maximum number of new shares:                    2,000,000
 
 Subscription price:                                               NOK 3.00
 
 Shall the rights be listed                                      No
 
 
The issuance of new shares in the Subsequent Offering will be subject to approval of the pertaining share capital increase by the EGM to be held on or about 12 November 2024. The Subsequent Offering is expected to be carried out during the notice period for the EGM, with a one-week subscription period, expected to expire at least three days prior to the date of the EGM.
 
This information is published in accordance with the requirements of the Continuing Obligations in Euronext Rule Book II.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts

Jan Aas Varming, CFO, Aqua Bio Technology ASA, +47 908 39 076, jan@aquabiotech.no

About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainablebiotechnology for use in skin care products. ABT’s cosmetics ingredients arehighly effective and they provide the cosmetics industry with naturalalternatives to traditional ingredients. ABT is also marketing and distributingnatural skin care products developed by partners towards consumers andprofessional users. Aqua Bio Technology is listed on Euronext Expand.
Attachments

Download announcement as PDF.pdf

Leave a Reply